An protocol of ongoing trial by Mary ER et al[33] is available online, which assess the effect of pentoxifylline on adipocyte-derived cytokines, leptin and adiponectin, and its effect on free fatty acid levels in patients with NASH, but we was not able to find the final report. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatohepatitis.